Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: a promising target for preventing progression of TNBC
暂无分享,去创建一个
S. Capitani | M. Marchisio | V. Bertagnolo | P. Lanuti | Silvia Grassilli | F. Brugnoli | Federica Vezzali | Yasamin Al-Qassab